Lifecore Biomedical, Inc.
LFCR
$6.10
-$0.085-1.38%
| 11/24/2024 | 08/25/2024 | 05/26/2024 | 02/25/2024 | 11/26/2023 | |
|---|---|---|---|---|---|
| Net Income | -146.22% | -50.92% | 81.97% | 142.82% | 211.03% |
| Total Depreciation and Amortization | 15.74% | -8.07% | -19.26% | -30.50% | -39.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 145.93% | 37.44% | -67.14% | -170.18% | -710.17% |
| Change in Net Operating Assets | -1,200.76% | 277.74% | -36.84% | -746.22% | -84.12% |
| Cash from Operations | -574.38% | 92.28% | 481.96% | 86.92% | 154.74% |
| Capital Expenditure | 42.03% | 32.88% | 63.24% | 11.96% | -10.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 42.03% | 32.88% | 57.25% | -215.10% | -10.73% |
| Total Debt Issued | 13.47% | -16.09% | -17.75% | 165.51% | -155.30% |
| Total Debt Repaid | -5,000.89% | -796.15% | 2.78% | 99.14% | -357.14% |
| Issuance of Common Stock | -- | -99.86% | -- | -- | -100.00% |
| Repurchase of Common Stock | -3,108.33% | -1,208.89% | -- | 82.72% | 91.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 95.51% | 232.90% | -- |
| Cash from Financing | 611.23% | -62.75% | -102.50% | 216.36% | -127.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.59% | 71.84% | -66.61% | 96.19% | -307.86% |
